Elliot S. Vesell

9.6k total citations · 1 hit paper
236 papers, 7.2k citations indexed

About

Elliot S. Vesell is a scholar working on Molecular Biology, Pharmacology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Elliot S. Vesell has authored 236 papers receiving a total of 7.2k indexed citations (citations by other indexed papers that have themselves been cited), including 89 papers in Molecular Biology, 73 papers in Pharmacology and 39 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Elliot S. Vesell's work include Pharmacogenetics and Drug Metabolism (68 papers), Metabolism and Genetic Disorders (30 papers) and Pharmaceutical studies and practices (22 papers). Elliot S. Vesell is often cited by papers focused on Pharmacogenetics and Drug Metabolism (68 papers), Metabolism and Genetic Disorders (30 papers) and Pharmaceutical studies and practices (22 papers). Elliot S. Vesell collaborates with scholars based in United States, China and Switzerland. Elliot S. Vesell's co-authors include G. Thomas Passananti, John G. Page, Alexander G. Bearn, Daniel W. Nebert, Gershon W. Hepner, Barry Dvorchik, Gabriel A. Kyerematen, Carol A. Shively, Margaret B. Penno and Paul J. Fritz and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Elliot S. Vesell

233 papers receiving 6.3k citations

Hit Papers

The antipyrine test in clinical pharmacology: Conceptions... 1979 2026 1994 2010 1979 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elliot S. Vesell United States 47 2.3k 2.3k 941 935 810 236 7.2k
Robert L. Smith United Kingdom 54 3.7k 1.6× 2.0k 0.9× 701 0.7× 956 1.0× 1.6k 2.0× 303 11.2k
Steven Schenker United States 55 1.6k 0.7× 1.5k 0.7× 1.4k 1.5× 1.1k 1.1× 913 1.1× 172 10.2k
W. Kalow Canada 57 3.2k 1.4× 4.0k 1.8× 1.2k 1.3× 685 0.7× 1.6k 1.9× 237 11.1k
Thomas R. Tephly United States 54 4.2k 1.8× 4.2k 1.9× 1.9k 2.0× 592 0.6× 2.3k 2.8× 175 10.4k
Emanuel Rubin United States 57 3.5k 1.5× 1.3k 0.6× 441 0.5× 1.5k 1.7× 460 0.6× 228 10.9k
Albrecht Wendel Germany 57 4.6k 2.0× 1.7k 0.8× 342 0.4× 1.4k 1.4× 1.0k 1.3× 209 14.2k
Russell A. Prough United States 49 2.9k 1.2× 2.5k 1.1× 377 0.4× 761 0.8× 1.1k 1.4× 199 7.7k
Gérard Siest France 61 4.1k 1.8× 2.5k 1.1× 1.2k 1.2× 2.3k 2.5× 1.7k 2.1× 519 14.5k
Robert J. Williams United Kingdom 61 4.0k 1.7× 1.9k 0.8× 447 0.5× 2.1k 2.2× 791 1.0× 271 14.5k
Dominique Pessayre France 69 4.2k 1.8× 5.0k 2.2× 697 0.7× 1.4k 1.5× 2.1k 2.6× 248 14.6k

Countries citing papers authored by Elliot S. Vesell

Since Specialization
Citations

This map shows the geographic impact of Elliot S. Vesell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elliot S. Vesell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elliot S. Vesell more than expected).

Fields of papers citing papers by Elliot S. Vesell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elliot S. Vesell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elliot S. Vesell. The network helps show where Elliot S. Vesell may publish in the future.

Co-authorship network of co-authors of Elliot S. Vesell

This figure shows the co-authorship network connecting the top 25 collaborators of Elliot S. Vesell. A scholar is included among the top collaborators of Elliot S. Vesell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elliot S. Vesell. Elliot S. Vesell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vesell, Elliot S.. (1996). Reflections from Distant Cuvettes. Drug Metabolism Reviews. 28(4). 493–511. 2 indexed citations
2.
A-Rahim, Yousif I., et al.. (1996). Studies on Pyrazinoylguanidine. Pharmacology. 53(4). 211–218. 2 indexed citations
3.
Schmucker, Douglas L. & Elliot S. Vesell. (1993). Underrepresentation of women in clinical drug trials. Clinical Pharmacology & Therapeutics. 54(1). 11–15. 35 indexed citations
4.
Vesell, Elliot S., Charles E. Chambers, G. Thomas Passananti, Laurence M. Demers, & Karl H. Beyer. (1993). Effects of Pyrazinoylguanidine on the Glucose‐Fatty Acid Cycle in Normal Subjects and Patients with Non‐Insulin‐Dependent Diabetes Mellitus. The Journal of Clinical Pharmacology. 33(9). 823–831. 5 indexed citations
6.
Vesell, Elliot S.. (1991). Genetic and environmental factors causing variation in drug response. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 247(2). 241–257. 13 indexed citations
7.
Anderson, Karl E., et al.. (1991). Diet and cimetidine induce comparable changes in theophylline metabolism in normal subjects. Hepatology. 13(5). 941–946. 15 indexed citations
8.
Kimberling, William J., David E. Goldgar, Margaret B. Penno, & Elliot S. Vesell. (1987). Pharmacogenetic application of methods from population genetics. Clinical Pharmacology & Therapeutics. 41(1). 3–10. 3 indexed citations
9.
Shively, Carol A., Stanley M. Tarka, Maurice J. Arnaud, et al.. (1985). High levels of methylxanthines in chocolate do not alter theobromine disposition. Clinical Pharmacology & Therapeutics. 37(4). 415–424. 29 indexed citations
10.
Sultatos, Lester G., Elliot S. Vesell, & Gershon W. Hepner. (1978). Aminopyrine disposition: A sensitive index of acetaminophen-induced hepatocellular damage. Toxicology and Applied Pharmacology. 45(1). 177–189. 12 indexed citations
11.
Vesell, Elliot S., Carol A. Shively, & G. Thomas Passananti. (1977). Temporal variations of antipyrine half‐life in man. Clinical Pharmacology & Therapeutics. 22(6). 843–852. 19 indexed citations
12.
Vesell, Elliot S., et al.. (1975). Effects of various barbiturates on hepatic microsomal enzymes. A comparative study.. PubMed. 2(5). 448–57. 32 indexed citations
13.
Aurori, Kevin C. & Elliot S. Vesell. (1974). COMPARATIVE STIMULATORY EFFECTS OF FOUR PHENOTHIAZINES ON HEPATIC MICROSOMAL ENZYMES. Drug Metabolism and Disposition. 2(6). 566–572. 5 indexed citations
14.
Vesell, Elliot S.. (1971). Drug metabolism in man. New York Academy of Sciences eBooks. 23 indexed citations
15.
Vesell, Elliot S., G. Thomas Passananti, & Frank E. Greene. (1970). Impairment of Drug Metabolism in Man by Allopurinol and Nortriptyline. New England Journal of Medicine. 283(27). 1484–1488. 114 indexed citations
16.
Wurtman, Richard J., Julius Axelrod, Elliot S. Vesell, & Griff T. Ross. (1968). Species Differences in Inducibility of Phenylethanolamine-N-Methyl Transferase. Endocrinology. 82(3). 584–590. 45 indexed citations
17.
Vesell, Elliot S. & John G. Page. (1968). Genetic Control of Drug Levels in Man: Antipyrine. Science. 161(3836). 72–73. 175 indexed citations
18.
Vesell, Elliot S.. (1965). Lactate Dehydrogenase Isozyme Patterns of Human Platelets and Bovine Lens Fibers. Science. 150(3704). 1735–1737. 29 indexed citations
19.
Vesell, Elliot S. & John Philip. (1963). ISOZYMES OF LACTIC DEHYDROGENASE: SEQUENTIAL ALTERATIONS DURING DEVELOPMENT. Annals of the New York Academy of Sciences. 111(1). 243–257. 15 indexed citations
20.
Vesell, Elliot S.. (1959). Urinary Test for a Metabolite of Prochlorperazine. New England Journal of Medicine. 260(21). 1078–1078. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026